Komori
Share Issuance and Disposal4571Nano Holdings,Inc.Pharmaceuticals

Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions)

In September 2026, 210,000 shares were delivered and 2,100 Series 22 Stock Acquisition Rights were exercised. The number of unexercised Stock Acquisition Rights stood at 250,370 at month-end.

Worth reading
55In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
210000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Exercise status report for stock acquisition rights with an exercise price adjustment clause

発行・処分する株式数

New shares: 210,000; treasury shares transferred: 0

発行済株式総数

0.29% (exercise ratio related to exercise restrictions; 210,000 shares delivered across all series combined / 71,981,758 listed shares as of the payment date for the issuance)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
¥94 during the reporting month (¥96 from 1 to 14 September). The detailed lower limit under the adjustment clause is Not disclosed
Number of Stock Acquisition Rights
Total number issued: Not disclosed. Unexercised balance of 252,470 units as of the end of the month preceding the reporting month, and 250,370 units as of the end of the reporting month
Procedures under the Corporate Code of Conduct
Report on compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Regulations on Listing of Securities and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financing
The 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025
Details of issuance or disposal
ItemDetails
Type of issuance or disposalExercise status report for stock acquisition rights with an exercise price adjustment clause
Number of shares to be issued or disposed ofNew shares: 210,000; treasury shares transferred: 0
Dilution Rate0.29% (exercise ratio related to exercise restrictions; 210,000 shares delivered across all series combined / 71,981,758 listed shares as of the payment date for the issuance)
Total number of issued shares90,735,458 shares (as of the end of the month preceding the reporting month) → Not disclosed
Exercise price¥94 during the reporting month (¥96 from 1 to 14 September). The detailed lower limit under the adjustment clause is Not disclosed
Number of Stock Acquisition RightsTotal number issued: Not disclosed. Unexercised balance of 252,470 units as of the end of the month preceding the reporting month, and 250,370 units as of the end of the reporting month
Procedures under the Corporate Code of ConductReport on compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Regulations on Listing of Securities and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters
Most recent equity financingThe 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the monthly exercise status of the 22nd series of stock acquisition rights for September 2026.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Monthly Exercise Status of the 22nd Stock Acquisition Rights (with Exercise Price Adjustment Provisions) | Nano Holdings,Inc. (4571) timely disclosure | Komori